Construction of artificial intelligence health management platform based on dysfunction of Shaoyang for the treatment of metabolic syndrome and prevention of ischemic cerebrovascular disease.
Not Applicable
- Conditions
- Metabolic syndrome, ischemic cerebrovascular disease
- Registration Number
- ITMCTR2000003286
- Lead Sponsor
- Shanghai Sixth People's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. In line with the diagnostic criteria of western medicine namely metabolic syndrome patients.
2. In accordance with the Chinese medicine shaoyang cardinal adverse syndrome of the patients, the age between 18 and 70 years old, men and women are not limited.
3. Informed consent, signed informed consent, and voluntary test.
Exclusion Criteria
1. Pregnant or lactating women;
2. Type 1 diabetes and gestational diabetes and other types of diabetes, secondary hypertension and/or hyperlipidemia;
3. There are serious complications such as heart, liver, kidney or other serious primary diseases associated with mental illness patients.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method blood glucose;Objective index of the four diagnosis of TCM;blood fat;blood pressure;
- Secondary Outcome Measures
Name Time Method Pulse wave velocity and ankle-brachial index were detected;